| Abstrakt: |
An examination of corporate R&D expenditure and science publication patterns is presented. In general, large corporations with traditionally excellent research centres maintain a strong science publication performance. However, large companies with correspondingly significant R&D expenditures, such as the top two automobile manufacturers, can exhibit relatively poor scientific publication performance per R&D dollar spent, depending upon the industrial sector. Pharmaceutical companies, typically with 20,000 to 40,000 employees, exhibit R&D expenditures of the order of 6.5 to 12% of sales. These companies achieve the highest individual and aggregate publication performance, per R&D dollar invested. Smaller, high–technology firms, often with fewer than 5000 employees, evidence little or no science publication contributions. In these firms, either product development assumes R&D expenditures or technology transfer via scientific publication is not taking place. Hence, corporate restructuring and disaggregation may significantly alter the nature of the technological enterprise. |
